Curanex Pharmaceuticals Inc Common Stock (NASDAQ: CURX) last traded at $5.31, up 11.55% on the session. The quote above updates while this page is open; the figures below are drawn from Curanex Pharmaceuticals Inc Common Stock’s own filings and are restated only when a new one is published.
Curanex Pharmaceuticals Inc Common Stock trades on NASDAQ under the ticker CURX. Its market capitalisation is $166.55 million.
Valuation measures for Curanex Pharmaceuticals Inc Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $166.55M |
|---|---|
| Enterprise value | $163.89M |
| Price / book | 34.79 |
| Beta | 1.03 |
Trailing-twelve-month figures tagged in Curanex Pharmaceuticals Inc Common Stock's XBRL filings with the SEC.
| Net income (TTM) |
|---|
| -$10.47M |
| EPS (TTM) | -$0.390 |
|---|
| Return on equity | -218.65% |
|---|
| Cash | $2.94M |
|---|
Range and volume for CURX over the past 52 weeks.
| 52-week high | $16.94 |
|---|---|
| 52-week low | $3.58 |
| Volume | 17.1K |
| Average volume | 19.8K |
| Previous close | $4.76 |
Invest a chosen dollar amount in Curanex Pharmaceuticals Inc Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell CURX.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.